DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

International Drug & Explosives Detection Company IDenta Corporation Announces Additional Details With Expobrax Export & Import Ltd.


7/19/2011 11:02:06 AM

JERUSALEM, July 18, 2011 /PRNewswire/ -- IDenta Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham today announced additional details of the agreement with Expobrax Export & Import Ltd.

Mr. Shoham stated, "I want to give a broader picture regarding the agreement signed between IDenta Corp. and the Brazilian company, Expobrax Export & Import Ltd. www.expobrax.com.Br

IDenta Corp. had revealed the connection with the Brazilian company in the press release from June 7, 2011.

The owner of the Brazilian company is Cesar Couto.

The agreement was signed recently after Mr. Couto personally checked with and made connections with many different Brazilian homeland security agencies.

The Brazilian company is committed to purchasing IDenta's kits for a minimum of 200,000 USD for the first year of the agreement.

Mr. Couto has tested IDenta's detectors before several different agencies.

Here are some of his e-mails sent to us in the past weeks.

1. Nothing is better than a video...

Yesterday we had our first meeting and product demonstration for the State Police authorities in Rio. The IDenta product was approved beyond all expectancies for its reliability and working simplicity. I was given all details and was invited to participate in the first purchase tender to come in August. The first purchase will be something around 8 to 10 thousand units.

That's the first step, after that, the sky is the limit. On the other hand, our preparatory program for IDenta's products is on the way. The site development and folder design are already contracted to be ready in 30 days. Meanwhile, lots of retail sales training, visits and meetings are being prepared in advance.

I'll keep you abreast of everything.

Regards, Cesar

2. Yes, even on a new drug called "OXI" that comes from cocaine mixed with gasoline, diesel oil, etc. This new drug is becoming a real problem because of its smaller price and high level of addiction...

We've used 8 capsules on different drugs from cocaine, crack, marijuana, Ecstasy, LSD and heroin, and it was a complete success...

Cesar Couto

More information about OXI drug see the following link: http://riotimesonline.com/brazil-news/front-page/oxi-new-drug-terrifies-brazil/

3. A new drug from Bolivia and Colombia is now devastating Brazilian youth. Different from crack which is mixed with bicarbonate and ammoniac, this drug - called OXI - comes from the cocaine basic pasta and is mixed with kerosene and lime to be very cheap. It's sold as a small stone (like crack) to be smoked as a piece of crack and is becoming a real problem because of its smaller price and high level of addiction (five times worse than cocaine). The OXI effects are terrible and their addicts lose teeth, weight and become addicted very fast...

Since it has the same active principle of cocaine, it can be identified by our IDenta capsules as cocaine. We have tested it successfully during our first experimentation in the State Police Headquarters.

Cesar

IDenta's entire product line may be found at www.Identa-corp.comwww.drugsdetector.com and www.Identa.biz

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.drugsdetector.comwww.identa.biz. www.identa-corp.com

Contact:
Contact:
Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
fpi@drugsdetector.com
http://www.identa.biz

SOURCE IDenta Corp.


Read at BioSpace.com


 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->